

Instance: composition-en-36a6a5465117f75ed9e0484773e74fde
InstanceOf: CompositionUvEpi
Title: "Composition for pirfenidone Package Leaflet"
Description:  "Composition for pirfenidone Package Leaflet"
Usage: #inline

* identifier.system = ""

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - pirfenidone"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet </p>
<ol>
<li>What Pirfenidone Viatris is and what it is used for </li>
<li>What you need to know before you take Pirfenidone Viatris </li>
<li>How to take Pirfenidone Viatris </li>
<li>Possible side effects </li>
<li>How to store Pirfenidone Viatris </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What pirfenidone is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What pirfenidone is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Pirfenidone Viatris contains the active substance pirfenidone and it is used for the treatment of 
Idiopathic Pulmonary Fibrosis (IPF) in adults. </p>
<p>IPF is a condition in which the tissues in your lungs become swollen and scarred over time, and as a 
result makes it difficult to breathe deeply. This makes it hard for your lungs to work properly. 
Pirfenidone Viatris helps to reduce scarring and swelling in the lungs, and helps you breathe better. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take pirfenidone"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take pirfenidone"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Pirfenidone Viatris 
* if you are allergic to pirfenidone or any of the other ingredients of this medicine (listed in 
section 6) 
* if you have previously experienced angioedema with pirfenidone, including symptoms such as 
swelling of the face, lips and/or tongue which may be associated with difficulty breathing or 
wheezing 
* if you are taking a medicine called fluvoxamine (used to treat depression and obsessive 
compulsive disorder [OCD]) 
* if you have severe or end stage liver disease 
* if you have severe or end stage kidney disease requiring dialysis. </p>
<p>If any of the above affects you, do not take Pirfenidone Viatris. If you are unsure ask your doctor or 
pharmacist. </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking Pirfenidone Viatris 
* You may become more sensitive to sunlight (photosensitivity reaction) when taking Pirfenidone 
Viatris. 
* Avoid the sun (including sunlamps) whilst taking Pirfenidone Viatris. Wear sunblock daily and 
cover your arms, legs and head to reduce exposure to sunlight (see section 4: Possible side 
effects). 
* You should not take other medicines, such as tetracycline antibiotics (such as doxycycline), 
which may make you more sensitive to sunlight. 
* You should tell your doctor if you suffer from kidney problems. 
* You should tell your doctor if you suffer from mild to moderate liver problems. 
* You should stop smoking before and during treatment with Pirfenidone Viatris. Cigarette 
smoking can reduce the effect of Pirfenidone Viatris. 
* Pirfenidone Viatris may cause dizziness and tiredness. Be careful if you have to take part in 
activities where you have to be alert and co-ordinated. 
* Pirfenidone Viatris can cause weight loss. Your doctor will monitor your weight whilst you are 
taking this medicine. 
* Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported in association 
with pirfenidone treatment. Stop using Pirfenidone Viatris and seek medical attention 
immediately if you notice any of the symptoms related to these serious skin reactions described 
in section 4. Pirfenidone Viatris may cause serious liver problems and some cases have been fatal. You will need a 
blood test before you start taking Pirfenidone Viatris and at monthly intervals for the first 6 months and 
then every 3 months thereafter whilst you are taking this medicine to check whether your liver is 
working properly. It is important that you have these regular blood tests for as long as you are taking 
Pirfenidone Viatris </p>
<p>Children and adolescents 
Do not give Pirfenidone Viatris to children and adolescents under the age of 18. Other medicines and Pirfenidone Viatris 
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other 
medicines. </p>
<p>This is especially important if you are taking the following medicines, as they may change the effect of 
Pirfenidone Viatris. </p>
<p>Medicines that may increase side effects of Pirfenidone Viatris: 
* enoxacin (a type of antibiotic) 
* ciprofloxacin (a type of antibiotic) 
* amiodarone (used to treat some types of heart disease) 
* propafenone (used to treat some types of heart disease) 
* fluvoxamine (used to treat depression and obsessive compulsive disorder (OCD)). </p>
<p>Medicines that may reduce how well Pirfenidone Viatris works: 
* omeprazole (used in the treatment of conditions such as indigestion, gastroesophageal reflux 
disease) 
* rifampicin (a type of antibiotic). </p>
<p>Pirfenidone Viatris with food and drink 
Do not drink grapefruit juice whilst taking this medicine. Grapefruit may prevent Pirfenidone Viatris 
from working properly. </p>
<p>Pregnancy and breast-feeding 
As a precautionary measure, it is preferable to avoid the use of Pirfenidone Viatris if you are pregnant, 
planning to become pregnant or think you might be pregnant as the potential risks to the unborn child 
are unknown. </p>
<p>If you are breast-feeding or plan to breast-feed speak to your doctor or pharmacist before taking 
Pirfenidone Viatris. As it is unknown whether Pirfenidone Viatris passes into breast milk, your doctor 
will discuss the risks and benefits of taking this medicine while breast-feeding if you decide to do so. </p>
<p>Driving and using machines 
Do not drive or use machines if you feel dizzy or tired after taking Pirfenidone Viatris. </p>
<p>Pirfenidone Viatris contains sodium 
This medicine contains less than 1 mmol (23 mg) sodium per tablet, that is to say essentially 'sodium-
free'. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take pirfenidone"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take pirfenidone"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Treatment with Pirfenidone Viatris should be started and overseen by a specialist doctor experienced 
in the diagnosis and treatment of IPF. </p>
<p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor 
or pharmacist if you are not sure. </p>
<p>Your medicine will usually be given to you in increasing doses as follows: 
* for the first 7 days take a dose of 267 mg (1 yellow tablet), 3 times a day with food (a total of 
801 mg/day 
* from day 8 to 14 take a dose of 534 mg (2 yellow tablets or 1 orange tablet), 3 times a day with 
food (a total of 1 602 mg/day) 
* from day 15 onwards (maintenance), take a dose of 801 mg (3 yellow tablets or 1 brown tablet), 
3 times a day with food (a total of 2 403 mg/day). </p>
<p>The recommended maintenance daily dose of Pirfenidone Viatris is 801 mg (3 yellow tablets or 1 
brown tablet) three times a day with food, for a total of 2 403 mg/day. </p>
<p>Swallow the tablets whole with a drink of water, during or after a meal to reduce the risk of side 
effects such as nausea (feeling sick) and dizziness. If symptoms continue, see your doctor. </p>
<p>Dose reduction due to side effects 
Your doctor may reduce your dose if you suffer from side effects such as, stomach problems, any skin 
reactions to sunlight or sun lamps, or significant changes to your liver enzymes. </p>
<p>If you take more Pirfenidone Viatris than you should 
Contact your doctor, pharmacist or nearest hospital casualty department immediately if you have taken 
more tablets than you should, and take your medicine with you. </p>
<p>If you forget to take Pirfenidone Viatris 
If you forget a dose, take it as soon as you remember. Do not take a double dose to make up for a 
forgotten dose. Each dose should be separated by at least 3 hours. Do not take more tablets each day 
than your prescribed daily dose. </p>
<p>If you stop taking Pirfenidone Viatris 
In some situations, your doctor may advise you to stop taking Pirfenidone Viatris. If for any reason 
you have to stop taking Pirfenidone Viatris for more than 14 consecutive days, your doctor will restart 
your treatment with dose of 267 mg 3 times a day, gradually increasing this to a dose of 801 mg 
3 times a day. 
If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Stop taking Pirfenidone Viatris and tell your doctor immediately 
* If you experience swelling of the face, lips and/or tongue, itching, hives, difficulty breathing or 
wheezing, or feeling faint, which are signs of angioedema, a serious allergic reaction or 
anaphylaxis. 
* If you experience yellowing of the eyes or skin, or dark urine, potentially accompanied by 
itching of the skin, pain on the upper right side of your stomach area (abdomen), loss of 
appetite, bleeding or bruising more easily than normal, or feeling tired. These may be signs of 
abnormal liver function and could indicate liver injury, which is an uncommon side effect of 
Pirfenidone Viatris. 
* If you experience reddish non-elevated, or circular patches on the trunk, often with central 
blisters, skin peeling, ulcers of mouth, throat, nose, genitals and eyes. These serious skin 
rashes can be preceded by fever and flu-like symptoms. These signs and symptoms may 
indicate Stevens-Johnson syndrome or toxic epidermal necrolysis. </p>
<p>Other side effects may include 
Talk to your doctor if you get any side effects. </p>
<p>Very common (may affect more than 1 in 10 people) 
* infections of the throat or the airways going into the lungs and/or sinusitis 
* feeling sick (nausea) 
* stomach problems such as acid reflux, vomiting and feeling constipated 
* tiredness 
* diarrhoea 
* indigestion or stomach upset 
* weight loss 
* decreased appetite 
* difficulty sleeping 
* headache 
* dizziness 
* shortness of breath 
* cough 
* aching joints/joint pains. </p>
<p>Common (may affect up to 1 in 10 people) 
* bladder infections 
* feeling sleepy 
* changes in taste 
* hot flushes 
* stomach problems such as feeling bloated, abdominal pain and discomfort, heart burn and 
passing wind 
* blood tests may show increased levels of liver enzymes 
* skin reactions after going out in the sun or using sunlamps 
* skin problems such as itchy skin, skin redness or red skin, dry skin, skin rash 
* muscle pain 
* feeling weak or feeling low in energy 
* chest pain 
* sunburn. </p>
<p>Uncommon (may affect up to 1 in 100 people) 
* Low levels of sodium in the blood. This may cause headache, dizziness, confusion, weakness, 
muscle cramps or nausea and vomiting 
* blood tests may show decrease in white blood cells. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist This includes any possible side effects not 
listed in this leaflet. You can also report side effects directly via the national reporting system listed in 
Appendix V. By reporting side effects you can help provide more information on the safety of this 
medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store pirfenidone"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store pirfenidone"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The 
expiry date refers to the last day of that month. </p>
<p>This medicinal product does not require any special storage conditions. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Pirfenidone Viatris contains </p>
<p>The active substance is pirfenidone. Each film-coated tablet contains 267 mg, 534 mg or 801 mg of 
pirfenidone. </p>
<p>The other ingredients are: </p>
<p>Tablet core 
Cellulose, microcrystalline (E 460) 
Croscarmellose sodium (E 468) (see section 2,  Pirfenidone Viatris contains sodium ) 
Povidone (E 1201) 
Silica, colloidal anhydrous (E 551) 
Magnesium stearate (E 572) </p>
<p>Film coat 
Poly (vinyl alcohol) (E 1203) 
Titanium dioxide (E 171) 
Macrogol (E 1521) 
Talc (E 553b) </p>
<p>267 mg film-coated tablet 
Iron oxide yellow (E 172) </p>
<p>534 mg film-coated tablet 
Iron oxide yellow (E 172) 
Iron oxide red (E 172) 
801 mg film-coated tablet 
Ferric oxide black (E 172) 
Iron oxide red (E 172) </p>
<p>What Pirfenidone Viatris looks like and contents of the pack </p>
<p>267 mg film-coated tablet 
Pirfenidone Viatris 267 mg film-coated tablets are yellow, oval, biconvex film-coated tablets. 
Pirfenidone Viatris is available in blister packs containing 63, 90 or 252 film-coated tablets, calendar 
packs containing 63 or 252 film-coated tablets or perforated unit dose blister packs containing 63 x 1 
or 252 x 1 film-coated tablets. </p>
<p>The 267 mg blisters strips contained in the calendar packs are each marked with the following 
symbols and abbreviated names of the day as a reminder to take a dose three times a day: </p>
<p>MON. TUE. WED. THU. FRI. SAT. SUN. </p>
<p>534 mg film-coated tablet 
Pirfenidone Viatris 534 mg film-coated tablets are orange, oval, biconvex film-coated tablets. 
Pirfenidone Viatris is available in blister packs containing 21 or 84 film-coated tablets or 
perforated unit dose blister packs containing 21 x 1 film-coated tablets. </p>
<p>801 mg film-coated tablet 
Pirfenidone Viatris 801 mg film-coated tablets are brown, oval, biconvex film-coated tablets. 
Pirfenidone Viatris is available in blister packs containing 84, 90 or 252 film-coated tablets, 
calendar packs containing 84 film-coated tablets or perforated unit dose blister packs containing 
84 x 1 film-coated tablets. </p>
<p>The 801 mg blisters strips contained in the calendar packs are each marked with the following 
symbols and abbreviated names of the day as a reminder to take a dose three times a day: </p>
<p>MON. TUE. WED. THU. FRI. SAT. SUN. </p>
<p>Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder </p>
<p>Viatris Limited 
Damastown Industrial Park 
Mulhuddart 
Dublin Dublin 
Ireland </p>
<p>Manufacturer </p>
<p>Laboratorios Liconsa S.A. 
Avda. Miralcampo, 7 
Pol gono Industrial Miralcampo 
19200 Azuqueca de Henares 
Guadalajara 
Spain </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
Mylan bvba/sprl 
T l/Tel: + 32 (0)2 658 61 Lietuva 
Mylan Healthcare UAB 
Tel: +370 5 205 1  </p>
<p>.: +359 2 44 55 Luxembourg/Luxemburg 
Mylan bvba/sprl 
T l/Tel: + 32 (0)2 658 61 (Belgique/Belgien) </p>
<p>esk  republika 
Viatris CZ s.r.o. 
Tel: + 420 222 004 Magyarorsz g 
Mylan EPD Kft. 
Tel.: + 36 1 465 2Danmark 
Viatris ApS 
Tlf: +45 28 11 69 Malta 
V.J. Salomone Pharma Ltd 
Tel: + 356 21 22 01 Deutschland 
Viatris Healthcare GmbH 
Tel: +49 800 0700 Nederland 
Mylan BV 
Tel: +31 (0)20 426 3Eesti 
BGP Products Switzerland GmbH Eesti 
filiaal 
Tel: + 372 6363 Norge 
Viatris AS 
Tlf: + 47 66 75 33 <br />
Generics Pharma Hellas <br />
 : +30 210 993 6 sterreich 
Arcana Arzneimittel GmbH 
Tel: +43 1 416 2Espa a 
Viatris Pharmaceuticals, S.L.U. 
Tel: + 34 900 102 Polska 
Mylan Healthcare Sp. z o.o. 
Tel.: + 48 22 546 64 France 
Viatris Sant<br />
T l: +33 4 37 25 75 Portugal 
Mylan, Lda. 
Tel: + 351 214 127 Hrvatska 
Viatris Hrvatska d.o.o. 
Tel: +385 1 23 50 Rom nia 
BGP Products SRL 
Tel: +40 372 579 Ireland 
Mylan Ireland Limited 
Tel: +353 1 8711Slovenija 
Viatris d.o.o. 
Tel: + 386 1 23 63  sland 
Icepharma hf. 
S mi: +354 540 8Slovensk  republika 
Viatris Slovakia s.r.o. 
Tel: +421 2 32 199 Italia 
Mylan Italia S.r.l. 
Tel: + 39 02 612 46Suomi/Finland 
Viatris Oy 
Puh/Tel: +358 20 720 9<br />
Varnavas Hadjipanayis Ltd 
 : +357 2220 7Sverige 
Viatris AB 
Tel: +46 (0)8 630 19 Latvija 
Mylan Healthcare SIA 
Tel: +371 676 055 United Kingdom (Northern Ireland) 
Mylan IRE Healthcare Limited 
Tel: +353 18711This leaflet was last revised in. </p>
<p>Other sources of information </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      

